• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

How Do Health Outcomes in the Richest Counties in the US Compare to Those of Average Citizens in Other Developed Nations?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • US had higher per capita spending on healthcare vs any other developed country at $9491 per capita (2015 data)
  • Emanuel et al. (JAMA Intern Med, 2020) assessed whether health outcomes of White US citizens living in the 1% and 5% richest counties are better than the health outcomes of average residents in other developed countries

METHODS:

  • Comparative effectiveness study
  • Participants
    • White US citizens living in either
      • The 1% highest-income counties in the US (n = 32)
      • The 5% highest-income counties in the US (n = 157)
    • All residents in 12 other developed countries
  • Study Design
    • Compared US outcomes with data from Australia, Austria, Canada, Denmark, Finland, France, Germany, Japan, the Netherlands, Norway, Sweden, and Switzerland
  • Primary outcomes
    • Infant and maternal mortality
    • 5-year survival of colon and breast cancer patients
    • 5-year survival of childhood acute lymphocytic leukemia patients
    • 30-day age-standardized case fatality after acute myocardial infarction (AMI)

RESULTS:

  • Infant and maternal mortality in 5% highest-income counties
    • Infant mortality rate: 4.01 per 1000
    • Maternal mortality rate: 10.85 per 1000
    • Both higher than the mean rates for any of the comparison countries
    • Even for highest 1% highest-income counties, maternal mortality is still higher
  • 5-year survival rates for colon cancer in the 5% highest-income counties was 67.2% (95% CI, 66.7 to 67.7%)
    • Higher than rates for average US citizens and average citizens of 6 countries
    • Comparable to rates for average citizens in 4 countries
    • Lower than rates for average citizens in 2 countries
  • 5-year survival rates for breast cancer were in the 5% highest-income counties was 92.0% (95% CI, 91.6 to 92.4%)
    • Higher than rates for average citizens in all 12 comparison countries
  • Among white children in the 5% highest-income counties, 5-year survival rates with acute lymphocytic leukemia was 92.6% (95% CI 90.7 to 94.2%)
    • Higher than the average rate in 1 country
    • Comparable to the average rate in 11 countries
  • Adjusted 30-day AMI case-fatality rate in the 5% highest-income counties was
    • 8% below the rate for all US citizens
    • 5% below the rate for US citizens in the 1% highest-income US counties
    • Estimates were comparable to the median outcome of other high-income countries

CONCLUSION:

  • White US citizens in the high-income counties often have better health outcomes than the average health outcomes of US citizens
  • However, wealthier White US citizens may have worse health outcomes than average citizens of other developed countries
  • Breast cancer survival is better in the US, but that may be related to increased mammography screening programs which will pick up tumors at an earlier stage but may not necessarily alter mortality rates
  • The authors conclude that for White citizens in wealthier US counties

…in general, the outcomes for these individuals are no better than for average citizens in many other developed countries, and for infant, maternal, and AMI mortality, privileged White US citizens often fare worse

Learn More – Primary Sources:

Comparing Health Outcomes of Privileged US Citizens With Those of Average Residents of Other Developed Countries

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Does Socioeconomic Status Affect Risk of Adverse Birth Outcomes?
High-Deductible Health Care Plans and Delayed Breast Cancer Treatment
Medicaid Expansion: Impact on Preterm Birth and Low Birth Weight

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site